BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Business

  Sosei Co., Ltd., HRA, And Sandoz/Hexal Australia To Conclude Sublicensing Agreement For “Morning After Pill” SOH-075

  December 21, 2005

   · 

  1 min read
• Pharm Country

  Applied DNA Sciences, Inc. Release: The Chinese Government Selects DNA Anti-Counterfeit Technology As The Official Standard For Multimedia Product Protection

  December 21, 2005

   · 

  3 min read
• Drug Development

  Theravance, Inc. Reports Additional Results From Clinical Studies With Investigational Antibiotic Telavancin

  December 21, 2005

   · 

  1 min read
• Business

  Crucell N.V. And DSM Biologics Announce PER.C6(R) Licensing Agreement With ZyStor Therapeutics

  December 21, 2005

   · 

  1 min read
• Business

  Crucell N.V. And DSM Biologics Announce Second PER.C6(R) License Agreement With Ferring Pharmaceuticals

  December 21, 2005

   · 

  1 min read
• China Biopharmaceuticals Holdings, Inc. Receives New Trading Symbol CHBP.OB

  December 21, 2005

   · 

  1 min read
• Drug Development

  AlphaRx Inc. Initiates Animal Study For Acusolin(TM), A Potential Eye Drop For Cataracts

  December 21, 2005

   · 

  1 min read
• Business

  Solazyme, Inc. Completes Financing Round

  December 21, 2005

   · 

  1 min read
• Drug Development

  Acusphere Inc. Reaches 700 Patient Enrollment Mark In AI-700 Phase 3 Trials

  December 21, 2005

   · 

  1 min read
• Drug Development

  Adherex Technologies Inc. Receives FDA Orphan Drug Designation For Eniluracil In Liver Cancer: Designation Provides Up To Seven Years Of Market Exclusivity Upon Regulatory Approval

  December 21, 2005

   · 

  1 min read